We currently intend to focus on target companies in the life sciences, biotechnology and healthcare sectors. 

We are led by our Chairman and Co-CEO David Rosenberg, who is the Co-CEO and co-president of Ladenburg Thalmann & Co. Inc., or Ladenburg; our Co-CEO David J. Strupp, Jr., who is the head of healthcare investment banking at Ladenburg, and our Chief Financial Officer Steven Kaplan, who is head of capital markets at Ladenburg. The team has worked together at Ladenburg since 2012. Ladenburg is a growth-focused boutique investment bank with experience providing capital markets and advisory services to public and private life sciences companies. (Note: This is a blank-check company (SPAC, or special-purpose acquisition company) formed under the laws of Delaware.)

(Note: Ignyte Acquisition priced its IPO on Jan. 27, 2021, according to its terms in the prospectus: 5 million units at $10 each to raise $50 million.)